Olivieri, Jacopo <br/><br/>
Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.  [electronic resource] 

 -  The oncologist  04 2017 
 - 422-431 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2016-0289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anthracyclines--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cardiotoxicity--drug therapy<br/>Doxorubicin--administration & dosage<br/>Drug Delivery Systems<br/>Female<br/>Heart--drug effects<br/>Heart Diseases--chemically induced<br/>Hodgkin Disease--complications<br/>Humans<br/>Liposomes--chemistry<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Risk Factors